DJ Biogen Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slipped 1.56% to $203.89 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.32% to 7,728.20 and Dow Jones Industrial Average falling 0.34% to 53,791.85.
This was the stock's second consecutive day of losses.
Biogen Inc. closed 7.20% below its 52-week high of $219.72, which the company achieved on June 29th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 0.77% to $259.80, Pfizer Inc. $(PFE)$ fell 1.59% to $26.62, and AbbVie Inc. $(ABBV)$ rose 0.85% to $250.09.
Trading volume (936,443) remained 329,545 below its 50-day average volume of 1.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 11, 2026.